Anushka Patel's Publications

About Anushka Patel's Publications

Chief Executive Officer, The George Institute for Global Health
  • Scientia Professor, Faculty of Medicine, UNSW Sydney
  • Cardiologist (Hon), Royal Prince Alfred Hospital
  • MBBS,
  • SM,
  • PhD,
  • FRACP ,
  • FAHMS,
  • GAICD

  • Management of Cardiovascular Risk Factors in Australian General Practice of Those at Highest Risk

    Australasian Epidemiologist Date published:

  • Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study

    American Heart Journal Date published:

  • Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

    European Heart Journal Date published:

  • Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice

    American Heart Journal Date published:

  • Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial

    Expert Review of Endocrinology & Metabolism Date published:

  • ADVANCE: Blood Pressure Lowering in Diabetes

    The Journal of Clinical Hypertension Date published:

  • ADVANCE: Blood Pressure Lowering in Diabetes

    The Journal of Clinical Hypertension Date published:

  • Recalibration of a Framingham risk equation for a rural population in India

    Journal of Epidemiology & Community Health Date published:

  • Cardiovascular risk: who should we treat, and how much should we stratify?

    Heart Date published:

  • Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR.

    Date published:

  • Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE

    Date published:

  • A NEW MODEL FOR PREDICTING THE RISK OF MAJOR CARDIOVASCULAR OUTCOMES IN PEOPLE WITH DIABETES

    Date published:

  • THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

    Date published:

  • THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

    Date published:

  • THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL

    Date published:

  • New perspectives in the treatment of the diabetic patient. ADVANCE Study

    Hipertensión y Riesgo Vascular Date published: